Iran's War Drained America's Arsenal in 100 Days — The Munitions Replenishment Supercycle That Will Define LMT, RTX, and NOC Through 2030
The United States fired more than 1,000 Tomahawk cruise missiles in the first weeks of Operation Epic Fury. It burned through THAAD and Patriot interceptors at rates the Pentagon never modeled for sustained combat. And when the ceasefire smoke cleared in April 2026, defense planners confronted an uncomfortable truth: America's precision munitions stockpiles are at their lowest levels since the Cold War ended — and refilling them will take the better part of a decade.
For investors in Lockheed Martin (LMT), RTX Corporation (RTX), and Northrop Grumman (NOC), this depletion isn't a temporary headline. It's the foundation of a multi-year replenishment supercycle that will generate sustained, high-margin revenue regardless of whether the Iran conflict reignites or fades into diplomatic negotiation. Here's what that means — and why Wall Street's current pricing may still be missing the magnitude of what's ahead.
📊 Related Stocks & ETFs at a Glance
| Ticker | Company / Fund | Sector | Relevance to Iran Replenishment Cycle |
|---|---|---|---|
| LMT | Lockheed Martin | Defense – Missiles & Systems | Primary manufacturer of Patriot PAC-3, THAAD interceptors, and JASSM; $194B backlog |
| RTX | RTX Corporation | Defense – Munitions & Radar | Tomahawk, AMRAAM, Standard Missile families; record $271B backlog; munitions output up 40% YoY |
| NOC | Northrop Grumman | Defense – Strategic Systems | B-21 Raider, munitions components, solid rocket motors; $96B backlog |
| GD | General Dynamics | Defense – Ordnance & Naval | Ammunition and ordnance production; naval combat systems replenishment |
| BA | Boeing | Defense – Aircraft & Weapons | JDAM kits, Harpoon missiles, P-8 Poseidon maritime patrol aircraft |
| LHX | L3Harris Technologies | Defense – Electronics & ISR | Counter-drone systems, electronic warfare; benefits from drone/counter-drone emphasis |
| AXON | Axon Enterprise | Defense Tech – Drones | Expanding into military drone segment; benefits from Pentagon's drone emphasis |
| ITA | iShares U.S. Aerospace & Defense ETF | ETF – Broad Defense | Broad sector exposure across defense primes and suppliers |
| DFEN | Direxion Daily Aerospace & Defense Bull 3X | ETF – Leveraged Defense | 3x leveraged exposure to defense sector; high risk/reward on replenishment thesis |
| XAR | SPDR S&P Aerospace & Defense ETF | ETF – Equal-Weight Defense | Equal-weighted; more exposure to mid-cap defense suppliers in replenishment chain |
| XLE | Energy Select Sector SPDR | ETF – Energy | Oil price sensitivity to Iran conflict escalation or ceasefire collapse |
| USO | United States Oil Fund | ETF – Crude Oil | Direct crude exposure; barometer for Iran-related supply disruption risk |
The Scale of the Depletion: Why This Isn't a Normal Restocking Cycle
To understand why the current moment is structurally different for defense primes, you need to grasp the sheer scale of what Operation Epic Fury consumed.
According to Pentagon comptroller disclosures, the Iran war's price tag has climbed to $29 billion, with roughly $24 billion tied directly to repairing or replacing equipment — munitions, drones, and aircraft. U.S. naval assets alone fired more than 850 Tomahawk Land Attack Missiles in the first month, with updated reporting pushing the total past 1,000. The military struck more than 13,000 targets across 39 days of intense operations before the initial ceasefire took effect.
These aren't numbers that get replaced with a purchase order and a few months of factory time. A CSIS analysis of munitions expenditure at the ceasefire found that:
- Replacing approximately 290 THAAD interceptors could take until the end of 2029
- Replenishing more than 1,000 Patriot interceptors is projected to wrap up in mid-2029
- Manufacturing lead times for advanced munitions have stretched to 36 months or more, with total production lot times reaching 52 months — over four years
This is not a one-quarter restocking event. This is a structural, multi-year procurement commitment that the Department of Defense has no choice but to fulfill, regardless of what happens geopolitically with Iran.
The Pentagon Knows It — And Is Throwing Money at the Problem
The Trump administration's response has been anything but subtle. The FY2027 defense budget request of $1.5 trillion represents a staggering 42% increase — the largest expansion in military spending since World War II. Within that request, plans are being mooted for an additional $200 billion in dedicated munitions funding to replace weapons used in the Iran conflict and expand production capacity for next-generation systems.
The 2026 spending bill already includes $6.3 billion for critical munitions, including $1.9 billion more than originally requested, plus $500 million specifically for solid rocket motor industrial base expansion — the supply chain bottleneck that has constrained every major missile program.
A newly created Munitions Acceleration Council, spearheaded by Deputy Secretary of Defense Steve Feinberg, is holding weekly calls with defense contractors to eliminate production bottlenecks. The urgency is palpable.
The Big Three: Where Each Prime Stands in the Replenishment Queue
Lockheed Martin (LMT): The Interceptor King
Lockheed Martin sits at the epicenter of the replenishment supercycle. The company manufactures both Patriot PAC-3 interceptors and THAAD missiles — the two systems most severely depleted during the Iran conflict. The Department of Defense has announced framework agreements to more than triple Patriot production from 600 to 2,000 interceptors per year and grow THAAD interceptor output from 96 to 400 missiles annually.
Lockheed entered 2026 with a record $194 billion backlog and projected revenue of $77.5–$80 billion for the year. But here's the critical point investors are overlooking: much of the replenishment revenue hasn't yet entered the backlog. The $200 billion supplemental funding request is still working through Congress, and multi-year procurement contracts for expanded interceptor production are being negotiated in real time.
The stock currently trades at roughly $530, well below its March 2026 all-time high of $672.30 — a nearly 21% drawdown triggered by a Q1 earnings miss and broader defense sector de-rating. For long-term investors, that gap between price and the magnitude of guaranteed future revenue warrants careful attention.
RTX Corporation (RTX): The Munitions Machine
If Lockheed is the interceptor king, RTX is the volume munitions powerhouse. The company signed five landmark framework agreements with the Department of Defense covering Tomahawk, AMRAAM, and the Standard Missile family — the workhorses of the Iran campaign.
RTX's Q1 2026 results tell a story of a company already operating at wartime tempo: $22.1 billion in adjusted revenue (up 9% YoY), adjusted EPS of $1.78 (up 21%), and a record backlog of $271 billion — a remarkable 25% increase year over year. Raytheon's operating margin hit 12.2%, driven by favorable program mix in land and air defense systems and munitions output up more than 40% year over year.
Yet even these impressive figures come with a caveat: the stock fell more than 11% after results because full-year adjusted sales guidance missed Wall Street's loftiest forecasts. This highlights a critical dynamic — the market is pricing defense stocks on quarterly execution, while the investment thesis is a multi-year structural story. Traders are worried about this quarter's margins. The bigger picture is that RTX has a decade of guaranteed munitions demand ahead of it.
Northrop Grumman (NOC): The Upstream Enabler
Northrop Grumman's role in the replenishment cycle is less visible than Lockheed's or RTX's headline missile programs, but it may be equally important. The company is a critical supplier of solid rocket motors — the component that sits at the base of virtually every missile supply chain and represents the single tightest bottleneck in American munitions production.
Northrop reported Q1 2026 net awards of $9.8 billion and a backlog of $96 billion, up from a record $95.7 billion at the end of FY2025. The stock is up approximately 29% in 2026, making it the best performer among the Big Three, partly because investors recognize its indispensable position in the munitions supply chain.
The $500 million in dedicated solid rocket motor industrial base funding in the 2026 spending bill flows directly through Northrop's order book. As the Pentagon works to eliminate production bottlenecks, Northrop's upstream position gives it pricing power and volume visibility that downstream assemblers don't enjoy.
The Paradox: Why Defense Stocks Dropped During a War
One of the most counterintuitive aspects of 2026 has been the underperformance of defense stocks during active military operations. The iShares U.S. Aerospace & Defense ETF (ITA) dropped roughly 12% from early March through late April, even as the S&P 500 gained 3.5% over the same period.
Several factors explain this disconnect:
- Earnings execution gaps: LMT tumbled 13% and RTX fell 11% on Q1 results that missed elevated expectations. Investors had priced in war-driven upside, and when quarterly numbers didn't immediately reflect it, the sell-off was swift.
- Revenue timing mismatch: War spending doesn't flow to contractors instantly. Supplemental appropriations take months to pass Congress, and contract negotiations add further delays. The munitions are being consumed today; the revenue won't fully materialize for 12–18 months.
- Ceasefire uncertainty: The April 7 ceasefire and Strait of Hormuz reopening triggered a "peace scare" — the market's reflexive assumption that conflict resolution eliminates the defense spending thesis.
- Rotation pressure: As oil prices moderated and broader equities rallied on ceasefire hopes, money rotated out of defensive positions and into cyclical growth.
This is where the replenishment thesis becomes crucial. Even in a best-case peace scenario, the munitions have already been fired. The stockpiles have already been drained. The $29 billion in equipment costs have already been incurred. The spending commitment exists independent of what happens next with Iran.
What Comes Next: Three Scenarios for Defense Investors
Scenario 1: Ceasefire Holds, Diplomatic Resolution (Moderately Bullish)
Even in this most benign outcome, the replenishment supercycle proceeds. The Pentagon has no choice but to rebuild its depleted arsenals — doing otherwise would leave the U.S. strategically vulnerable in a world where China, Russia, and regional adversaries are watching closely. The $200 billion supplemental munitions request and the $1.5 trillion FY2027 budget are political realities that don't disappear with a peace agreement.
In this scenario, defense stocks may face near-term headline risk as "peace dividend" narratives circulate, but the revenue trajectory over 2027–2030 remains locked in. Historically, post-conflict defense spending doesn't decline immediately — it takes 3–5 years for appropriations to normalize, and the current stockpile deficit is far more severe than any recent precedent.
Expected defense stock impact: Short-term volatility, but dips likely absorbed by institutional buyers who understand the backlog math.
Scenario 2: Fragile Ceasefire, Periodic Escalation (Most Bullish)
The most probable scenario — and the most favorable for defense equities — is a protracted, unstable peace punctuated by flare-ups. Every escalation headline reinforces the urgency of munitions replenishment and makes Congressional supplemental funding politically easier to approve.
In this environment, the geopolitical risk premium stays elevated, defense appropriations continue to receive bipartisan support, and the production ramp accelerates. Combined backlogs across the top five defense primes already exceed $700 billion — and that number would continue climbing.
Expected defense stock impact: Sustained multiple expansion as the market prices in higher-for-longer defense spending.
Scenario 3: Conflict Re-escalation (Bullish for Revenue, Complex for Stocks)
A full return to hostilities would dramatically accelerate munitions consumption while simultaneously straining production capacity further. Revenue would surge, but the market might paradoxically punish stocks on broader risk-off sentiment, concerns about execution capacity, and macroeconomic headwinds from renewed oil supply disruption.
This is the scenario where production capacity constraints become the binding variable. Lockheed can't produce 2,000 Patriot interceptors annually if it's already struggling to hit current targets. RTX can't ramp Tomahawk output if solid rocket motor supply is capped. The revenue ceiling is set not by demand but by industrial capacity — a dynamic that limits near-term upside while extending the duration of the cycle.
Expected defense stock impact: Near-term volatility and potential drawdown on broader risk-off, but massive long-term revenue lock-in.
The Production Bottleneck: The Risk Hiding Inside the Bull Case
No honest analysis of the defense replenishment thesis is complete without addressing the elephant in the room: can these companies actually deliver?
The defense industrial base has been operating with limited domestic capacity and fragile supplier networks for decades. A federal review found that energetic materials and munitions production — the explosive compounds at the heart of every weapon — are concentrated in a limited number of facilities. The conversion step, which produces energetic powders and compounds, represents a single point of failure in the supply chain.
Manufacturing lead times of 36+ months mean that even with unlimited funding, production rates won't match demand until 2029 or later. The Pentagon's own analysis acknowledges that it has more money to spend on munitions than it can actually spend — the constraint is physical production capacity, not dollars.
For investors, this creates a double-edged dynamic:
- The bull case: Capacity constraints extend the duration of the supercycle. Instead of a sharp revenue spike and decline, defense primes will see a long, steady production ramp that generates predictable, high-margin revenue through 2030 and potentially beyond.
- The bear case: Execution risk is real. If contractors miss production milestones, the market will punish them — as Q1 2026 earnings reactions already demonstrated. Margin pressure from supply chain costs, labor shortages, and facility expansion can compress profitability even as revenue grows.
Investment Considerations: Navigating the Replenishment Thesis
For investors considering exposure to the defense replenishment supercycle, several factors deserve attention:
Backlog Quality Over Stock Price Momentum
The combined $561 billion in backlogs across LMT ($194B), RTX ($271B), and NOC ($96B) represents the most visible multi-year revenue pipeline in any sector. In an economic environment where most companies struggle to forecast beyond 12 months, defense primes have 3–5 years of contracted demand. The current share prices, which have pulled back significantly from March 2026 highs, reflect quarterly earnings disappointments — not fundamental deterioration in the multi-year story.
The Margin Expansion Catalyst Most Analysts Are Underweighting
Production scaling is expensive upfront but margin-accretive over time. RTX's Raytheon segment already demonstrated this with 12.2% operating margins in Q1 2026, driven by volume leverage on air defense and munitions lines. As production rates climb toward target levels, fixed-cost absorption improves dramatically. The companies that are investing in capacity today will be harvesting margins in 2028–2030.
ETF vs. Individual Stock Exposure
Broad defense ETFs like ITA and XAR offer diversified exposure but dilute the replenishment thesis with commercial aerospace names that face different dynamics. Investors who believe specifically in the munitions replenishment cycle may find more concentrated exposure through individual positions in the three primes, though this comes with higher idiosyncratic risk. The equal-weighted XAR provides better exposure to mid-cap munitions suppliers and defense sub-contractors that also benefit from the production ramp.
The International Multiplier
The replenishment thesis isn't limited to U.S. procurement. NATO allies are racing to increase defense spending, with European allies achieving a 20% increase in 2025 and committing to a new 5% of GDP target by 2035. Ahead of the July 2026 Ankara summit, European allies are outpacing spending expectations. Every Patriot battery, every AMRAAM missile, and every integrated air defense system that a NATO ally orders flows through the same production lines at LMT, RTX, and NOC — adding volume without adding proportional overhead.
The Bottom Line: The Arsenal Has Already Been Emptied
The most important thing for investors to understand about the Iran conflict's impact on defense stocks is this: the spending commitment has already been made.
Over a thousand Tomahawks have been fired. Hundreds of THAAD and Patriot interceptors have been consumed. The Pentagon's comptroller has tallied $29 billion in direct costs. Congressional supplemental funding is moving through the legislative process. A $1.5 trillion defense budget has been requested. Production contracts have been signed.
Whether Iran's ceasefire holds, collapses, or evolves into something else entirely, the physical reality of empty missile magazines doesn't change. The United States cannot maintain strategic credibility with depleted arsenals while China accelerates its military buildup and Russia continues its operations in Ukraine's periphery.
For LMT, RTX, and NOC, the Iran war didn't just boost their stock prices for a quarter. It created a structural demand floor that will persist through the rest of this decade. The stocks may fluctuate on headlines, earnings beats, and misses. But the missiles will need to be built.
That's not a thesis that depends on war. It's a thesis that depends on math.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Always do your own research before making investment decisions. Defense stocks carry unique risks including political, regulatory, and execution risk. Past performance is not indicative of future results.
댓글
댓글 쓰기